Cargando…
Comparison of the effects of 7.2% hypertonic saline and 20% mannitol on whole blood coagulation and platelet function in dogs with suspected intracranial hypertension - a pilot study
BACKGROUND: Hyperosmolar therapy with either mannitol or hypertonic saline (HTS) is commonly used in the treatment of intracranial hypertension (ICH). In vitro data indicate that both mannitol and HTS affect coagulation and platelet function in dogs. The aim of this study was to compare the effects...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477108/ https://www.ncbi.nlm.nih.gov/pubmed/28629456 http://dx.doi.org/10.1186/s12917-017-1108-2 |
_version_ | 1783244725653864448 |
---|---|
author | Yozova, Ivayla D. Howard, Judith Henke, Diana Dirkmann, Daniel Adamik, Katja N. |
author_facet | Yozova, Ivayla D. Howard, Judith Henke, Diana Dirkmann, Daniel Adamik, Katja N. |
author_sort | Yozova, Ivayla D. |
collection | PubMed |
description | BACKGROUND: Hyperosmolar therapy with either mannitol or hypertonic saline (HTS) is commonly used in the treatment of intracranial hypertension (ICH). In vitro data indicate that both mannitol and HTS affect coagulation and platelet function in dogs. The aim of this study was to compare the effects of 20% mannitol and 7.2% HTS on whole blood coagulation using rotational thromboelastometry (ROTEM®) and platelet function using a platelet function analyzer (PFA®) in dogs with suspected ICH. Thirty client-owned dogs with suspected ICH needing osmotherapy were randomized to receive either 20% mannitol (5 ml/kg IV over 15 min) or 7.2% HTS (4 ml/kg IV over 5 min). ROTEM® (EXTEM® and FIBTEM® assays) and PFA® analyses (collagen/ADP cartridges) were performed before (T(0)), as well as 5 (T(5)), 60 (T(60)) and 120 (T(120)) minutes after administration of HTS or mannitol. Data at T(5), T(60) and T(120) were analyzed as a percentage of values at T(0) for comparison between groups, and as absolute values for comparison between time points, respectively. RESULTS: No significant difference was found between the groups for the percentage change of any parameter at any time point except for FIBTEM® clotting time. Within each group, no significant difference was found between time points for any parameter except for FIBTEM® clotting time in the HTS group, and EXTEM® and FIBTEM® maximum clot firmness in the mannitol group. Median ROTEM® values lay within institutional reference intervals in both groups at all time points, whereas median PFA® values were above the reference intervals at T(5) (both groups) and T(60) (HTS group). CONCLUSIONS: Using currently recommended doses, mannitol and HTS do not differ in their effects on whole blood coagulation and platelet function in dogs with suspected ICH. Moreover, no relevant impairment of whole blood coagulation was found following treatment with either solution, whereas a short-lived impairment of platelet function was found after both solutions. |
format | Online Article Text |
id | pubmed-5477108 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-54771082017-06-22 Comparison of the effects of 7.2% hypertonic saline and 20% mannitol on whole blood coagulation and platelet function in dogs with suspected intracranial hypertension - a pilot study Yozova, Ivayla D. Howard, Judith Henke, Diana Dirkmann, Daniel Adamik, Katja N. BMC Vet Res Research Article BACKGROUND: Hyperosmolar therapy with either mannitol or hypertonic saline (HTS) is commonly used in the treatment of intracranial hypertension (ICH). In vitro data indicate that both mannitol and HTS affect coagulation and platelet function in dogs. The aim of this study was to compare the effects of 20% mannitol and 7.2% HTS on whole blood coagulation using rotational thromboelastometry (ROTEM®) and platelet function using a platelet function analyzer (PFA®) in dogs with suspected ICH. Thirty client-owned dogs with suspected ICH needing osmotherapy were randomized to receive either 20% mannitol (5 ml/kg IV over 15 min) or 7.2% HTS (4 ml/kg IV over 5 min). ROTEM® (EXTEM® and FIBTEM® assays) and PFA® analyses (collagen/ADP cartridges) were performed before (T(0)), as well as 5 (T(5)), 60 (T(60)) and 120 (T(120)) minutes after administration of HTS or mannitol. Data at T(5), T(60) and T(120) were analyzed as a percentage of values at T(0) for comparison between groups, and as absolute values for comparison between time points, respectively. RESULTS: No significant difference was found between the groups for the percentage change of any parameter at any time point except for FIBTEM® clotting time. Within each group, no significant difference was found between time points for any parameter except for FIBTEM® clotting time in the HTS group, and EXTEM® and FIBTEM® maximum clot firmness in the mannitol group. Median ROTEM® values lay within institutional reference intervals in both groups at all time points, whereas median PFA® values were above the reference intervals at T(5) (both groups) and T(60) (HTS group). CONCLUSIONS: Using currently recommended doses, mannitol and HTS do not differ in their effects on whole blood coagulation and platelet function in dogs with suspected ICH. Moreover, no relevant impairment of whole blood coagulation was found following treatment with either solution, whereas a short-lived impairment of platelet function was found after both solutions. BioMed Central 2017-06-19 /pmc/articles/PMC5477108/ /pubmed/28629456 http://dx.doi.org/10.1186/s12917-017-1108-2 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Yozova, Ivayla D. Howard, Judith Henke, Diana Dirkmann, Daniel Adamik, Katja N. Comparison of the effects of 7.2% hypertonic saline and 20% mannitol on whole blood coagulation and platelet function in dogs with suspected intracranial hypertension - a pilot study |
title | Comparison of the effects of 7.2% hypertonic saline and 20% mannitol on whole blood coagulation and platelet function in dogs with suspected intracranial hypertension - a pilot study |
title_full | Comparison of the effects of 7.2% hypertonic saline and 20% mannitol on whole blood coagulation and platelet function in dogs with suspected intracranial hypertension - a pilot study |
title_fullStr | Comparison of the effects of 7.2% hypertonic saline and 20% mannitol on whole blood coagulation and platelet function in dogs with suspected intracranial hypertension - a pilot study |
title_full_unstemmed | Comparison of the effects of 7.2% hypertonic saline and 20% mannitol on whole blood coagulation and platelet function in dogs with suspected intracranial hypertension - a pilot study |
title_short | Comparison of the effects of 7.2% hypertonic saline and 20% mannitol on whole blood coagulation and platelet function in dogs with suspected intracranial hypertension - a pilot study |
title_sort | comparison of the effects of 7.2% hypertonic saline and 20% mannitol on whole blood coagulation and platelet function in dogs with suspected intracranial hypertension - a pilot study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477108/ https://www.ncbi.nlm.nih.gov/pubmed/28629456 http://dx.doi.org/10.1186/s12917-017-1108-2 |
work_keys_str_mv | AT yozovaivaylad comparisonoftheeffectsof72hypertonicsalineand20mannitolonwholebloodcoagulationandplateletfunctionindogswithsuspectedintracranialhypertensionapilotstudy AT howardjudith comparisonoftheeffectsof72hypertonicsalineand20mannitolonwholebloodcoagulationandplateletfunctionindogswithsuspectedintracranialhypertensionapilotstudy AT henkediana comparisonoftheeffectsof72hypertonicsalineand20mannitolonwholebloodcoagulationandplateletfunctionindogswithsuspectedintracranialhypertensionapilotstudy AT dirkmanndaniel comparisonoftheeffectsof72hypertonicsalineand20mannitolonwholebloodcoagulationandplateletfunctionindogswithsuspectedintracranialhypertensionapilotstudy AT adamikkatjan comparisonoftheeffectsof72hypertonicsalineand20mannitolonwholebloodcoagulationandplateletfunctionindogswithsuspectedintracranialhypertensionapilotstudy |